UF expert answers questions about the newly approved RSV vaccine
On May 3, the FDA approved a vaccine to prevent respiratory syncytial virus in older adults. Dr. Cindy Prins answers some common questions about RSV disease and the new vaccine.
On May 3, the FDA approved a vaccine to prevent respiratory syncytial virus in older adults. Dr. Cindy Prins answers some common questions about RSV disease and the new vaccine.
UF microbiologist and virus expert John Lednicky, Ph.D., shares his perspective on the current avian influenza, or bird flu, outbreak in the U.S.
A UF researcher with expertise in infectious bacteria offers commentary and perspective on extensively drug-resistant Shigella infections following a recent CDC warning.
In a wide-ranging discussion, UF's Emerging Pathogens Institute Director J. Glenn Morris, M.D., fields big-picture questions about the COVID-19 pandemic unfolding nationally and in Florida.
Kevin Bardosh isn’t like a lot of his co-workers at the University of Florida’s Emerging Pathogens Institute. Not only is he a qualitative social scientist in a sea of quantitative types, he’s also a long way from his home institution, the University of Edinburgh